| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0002-9343(81)90417-4 |
| P698 | PubMed publication ID | 7006384 |
| P2093 | author name string | W Gepts | |
| P M Lecompte | |||
| P433 | issue | 1 | |
| P304 | page(s) | 105-115 | |
| P577 | publication date | 1981-01-01 | |
| P1433 | published in | American Journal of Medicine | Q2842959 |
| P1476 | title | The pancreatic islets in diabetes | |
| P478 | volume | 70 |
| Q37587949 | A new view of the beta cell as an antigen-presenting cell and immunogenic target |
| Q36181380 | Administration of CD4+CD25highCD127- regulatory T cells preserves β-cell function in type 1 diabetes in children |
| Q42077041 | Aloe-Emodin Protects RIN-5F (Pancreatic β-cell) Cell from Glucotoxicity via Regulation of Pro-Inflammatory Cytokine and Downregulation of Bax and Caspase 3. |
| Q34609631 | An in vivo analysis of pancreatic protein and insulin biosynthesis in a rat model for non-insulin-dependent diabetes |
| Q40141398 | Analysis of the insulin gene in noninsulin-dependent diabetes |
| Q34565013 | Antibodies to a 64,000 Mr human islet cell antigen precede the clinical onset of insulin-dependent diabetes |
| Q34567725 | Antigen-specific immunotherapy for autoimmune disease: fighting fire with fire? |
| Q36974042 | Autoantibodies as mechanisms, markers, and mediators of B-cell disease |
| Q41605577 | Autoimmune diabetes. The role of autoantibody markers in the prediction and prevention of insulin-dependent diabetes mellitus. |
| Q71467697 | Cell-mediated immunity and immune complexes in the pathogenesis of type 1 (insulin-dependent) diabetes |
| Q70269326 | Cellular composition of the human diabetic pancreas |
| Q52042442 | Clearance of apoptotic beta-cells is reduced in neonatal autoimmune diabetes-prone rats. |
| Q38680333 | Combination Immunotherapy for Type 1 Diabetes |
| Q70358198 | Comparison of whole pancreas and pancreatic islet transplantation in controlling nephropathy and metabolic disorders of diabetes |
| Q28601170 | Complement gene variants in relation to autoantibodies to beta cell specific antigens and type 1 diabetes in the TEDDY Study |
| Q79156179 | Coxsackievirus-mediated hyperglycemia is enhanced by reinfection and this occurs independent of T cells |
| Q47867272 | Deciphering the Pathogenesis of Human Type 1 Diabetes (T1D) by Interrogating T Cells from the "Scene of the Crime". |
| Q71609406 | Diabetes mellitus in childhood |
| Q24314353 | Diabetes, defective pancreatic morphogenesis, and abnormal enteroendocrine differentiation in BETA2/neuroD-deficient mice |
| Q44241620 | Different role of saturated and unsaturated fatty acids in beta-cell apoptosis |
| Q34617065 | Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus |
| Q27012682 | Discovering probiotic microorganisms: in vitro, in vivo, genetic and omics approaches |
| Q41015653 | Effect of chronic hyperglycemia on in vivo insulin secretion in partially pancreatectomized rats. |
| Q49173574 | Effects of Cyclosporine Immunosuppression in Insulin-Dependent Diabetes Mellitus of Recent Onset |
| Q49172936 | Effects of cyclosporine in recent-onset juvenile type 1 diabetes: impact of age and duration of disease |
| Q70324095 | Endocrine pancreas in cystic fibrosis: An immunohistochemical study |
| Q28273485 | Epidemic obesity and type 2 diabetes in Asia |
| Q34238473 | Essential role for interferon-gamma and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice |
| Q40266585 | Etiologies of diabetes mellitus. |
| Q38163729 | Experimental reduction of B-cell mass: implications for the pathogenesis of diabetes |
| Q42517345 | Factors affecting and patterns of residual insulin secretion during the first year of type 1 (insulin-dependent) diabetes mellitus in children |
| Q41870796 | Fat-induced changes in mouse pancreatic islet insulin secretion, insulin biosynthesis and glucose metabolism |
| Q53919350 | Foetal origins of adult diseases: just a matter of stem cell number? |
| Q33610661 | Goals of treatment for type 2 diabetes: beta-cell preservation for glycemic control |
| Q35716720 | Harnessing memory adaptive regulatory T cells to control autoimmunity in type 1 diabetes |
| Q35810045 | How type II diabetes-related islet amyloid polypeptide damages lipid bilayers |
| Q40255395 | Humoral autoimmunity in insulin-dependent (type I) diabetes mellitus. A current assessment |
| Q34494434 | Hypoglycemic effect of Carica papaya leaves in streptozotocin-induced diabetic rats |
| Q36166499 | Identification and expansion of pancreatic stem/progenitor cells. |
| Q57782997 | Identification and mapping to chromosome 1 of a susceptibility locus for periinsulitis in non-obese diabetic mice |
| Q39465032 | Immunological concepts in insulin-dependent (type I) diabetes mellitus |
| Q63256840 | Immunoregulatory T-lymphocyte subset deficiency in newly diagnosed Type 1 (insulin-dependent) diabetes mellitus |
| Q73497919 | Immunotherapy for insulin-dependent diabetes mellitus in the "BB" rat |
| Q40427277 | In Vivo Cell Transformation: Neogenesis of Beta Cells from Pancreatic Ductal Cells |
| Q36773604 | In vivo beta-cell imaging with VMAT 2 ligands--current state-of-the-art and future perspective |
| Q39460713 | Increased susceptibility to streptozotocin-induced beta-cell apoptosis and delayed autoimmune diabetes in alkylpurine-DNA-N-glycosylase-deficient mice |
| Q77669774 | Induction of islet cell neogenesis in the adult pancreas: the partial duct obstruction model |
| Q35184167 | Inflammatory mediators and islet beta-cell failure: a link between type 1 and type 2 diabetes |
| Q37527826 | Inheritance and development of diabetes mellitus |
| Q33868162 | Intercellular adhesion molecule 1 is induced on isolated endocrine islet cells by cytokines but not by reovirus infection |
| Q73691167 | Interleukin-1-beta, tumor necrosis factor-alpha, insulin secretion and oral glucose tolerance in non-diabetic siblings of children with IDDM |
| Q36816053 | Interleukins: Biological Properties and Therapeutic Potential |
| Q39429460 | Intra-islet insulin-glucagon-somatostatin relationships |
| Q24655066 | Islet amyloid in type 2 diabetes, and the toxic oligomer hypothesis |
| Q40246548 | Islet cell antibodies in diabetes |
| Q70339007 | Islet cell surface and lymphocyte antibodies often precede the spontaneous diabetes in the BB rat |
| Q71297565 | Islet-cell regeneration in the diabetic hamster pancreas with restoration of normoglycaemia can be induced by a local growth factor(s) |
| Q70046698 | L3T4 and Lyt-2 T cells are both involved in the generation of low-dose streptozotocin-induced diabetes in mice |
| Q34619649 | Longitudinal noninvasive PET-based beta cell mass estimates in a spontaneous diabetes rat model |
| Q34877796 | Mechanisms of developmental programming of the metabolic syndrome and related disorders |
| Q34289042 | Metabolic abnormalities in children of non-insulin dependent diabetics |
| Q34631236 | Modulation of proinsulin messenger RNA after partial pancreatectomy in rats. Relationships to glucose homeostasis |
| Q40977313 | Neural cell adhesion molecule (N-CAM) is required for cell type segregation and normal ultrastructure in pancreatic islets |
| Q59058087 | Non-tolerance and autoantibodies to a transgenic self antigen expressed in pancreatic β cells |
| Q42019499 | Obliterative segmental sclerosis of pancreatic islets. A possible consequence of hypotensive shock in young BB rats |
| Q44323964 | On the origin of non-insulin dependent diabetes mellitus |
| Q48486122 | On the origin of non-insulin-dependent diabetes |
| Q49887565 | Organ donor pancreases for the study of human islet cell histology and pathophysiology: a precious and valuable resource. |
| Q93029127 | Pancreatic Islet Hyperplasia: A Potential Marker for Anabolic-Androgenic Steroid Use |
| Q72825174 | Peripheral blood T-cell subsets studied by monoclonal antibodies in Type 1 (insulin-dependent) diabetes: effect of blood glucose control |
| Q40893814 | Pharmacological approaches to the prevention of autoimmune diabetes |
| Q67298313 | Predominance of T lymphocytes in pancreatic islets and spleen of pre-diabetic non-obese diabetic (NOD) mice: a longitudinal study |
| Q34014474 | Preparation of (111)In-DTPA morpholino oligomer for low abdominal accumulation |
| Q63256830 | Prevalence of residual B-cell function related to age at onset and genetic profile in newly diagnosed type I diabetics |
| Q40158626 | Prevention and Therapy of Diabetes Mellitus |
| Q71565917 | Prevention of diabetes in rats by bone marrow transplantation |
| Q47678735 | Prevention of type 1 diabetes |
| Q70362223 | Production of monoclonal antibodies to islet cell surface antigens using hybridization of spleen lymphocytes from non-obese diabetic mice |
| Q37308802 | Protection of nonobese diabetic mice from autoimmune diabetes by reduction of islet mass before insulitis |
| Q33930292 | Quantification and three-dimensional imaging of the insulitis-induced destruction of beta-cells in murine type 1 diabetes |
| Q30364628 | Quantitative Impact of Plasma Clearance and Down-regulation on GLP-1 Receptor Molecular Imaging. |
| Q72705400 | Quantitative immunocytochemical study of islet cell populations in diabetic calmodulin-transgenic mice |
| Q57161079 | Replication of adult pancreatic-beta cells cultured on bovine corneal endothelial cell extracellular matrix |
| Q30301275 | Role of Type 1 Diabetes-Associated SNPs on Risk of Autoantibody Positivity in the TEDDY Study |
| Q57214866 | Selective β-Cell Loss and α-Cell Expansion in Patients with Type 2 Diabetes Mellitus in Korea |
| Q40473381 | Self and non-self antigen in diabetic autoimmunity: Molecules and mechanisms |
| Q72769456 | Spontaneous diabetes in BB rats: Evidence for a T cell dependent immune response defect |
| Q63256817 | Study of T-cell activation in Type I diabetic patients and pre-Type I diabetic subjects by cytometric analysis: Antigen expression defectin vitro |
| Q37086612 | Sympathetic innervation during development is necessary for pancreatic islet architecture and functional maturation |
| Q36335800 | T-cell cloning in human type I diabetes |
| Q77395969 | T-cell response to proinsulin and insulin in type 1 and pretype 1 diabetes |
| Q69990788 | T-lymphocyte subpopulations in insulin-dependent (type I) diabetes mellitus |
| Q38177093 | The HLA-IDDM association: implications for etiology and pathogenesis of IDDM. |
| Q39650599 | The biochemistry of diabetes |
| Q35654341 | The differentiation of the immune system towards anti-islet autoimmunity. Clinical prospects |
| Q35383488 | The effect of curcumin on human islet amyloid polypeptide misfolding and toxicity |
| Q35337561 | The effect of type-2-diabetes-related vascular endothelial dysfunction on skin physiology and activities of daily living |
| Q34283363 | The immunomodulator Linomide: role in treatment and prevention of autoimmune diabetes mellitus |
| Q37808121 | The new generation of beta-cells: replication, stem cell differentiation, and the role of small molecules |
| Q38662048 | Therapies to Preserve β-Cell Function in Type 1 Diabetes |
| Q34875345 | Tolerogenic vaccination reduced effector memory CD4 T cells and induced effector memory Treg cells for type I diabetes treatment |
| Q40110135 | Type I Diabetes Mellitus: A Chronic Autoimmune Disease? |
| Q35835104 | Virus persists in beta cells of islets of Langerhans and infection is associated with chemical manifestations of diabetes. II. Morphologic observations |
| Q47889466 | World Diabetes Day: Perspectives on immunotherapy of Type 1 Diabetes |
| Q70438245 | [Pathogenesis and immunotherapy of insulin-dependent (type I) diabetes mellitus] |
| Q36109279 | miR-375 gene dosage in pancreatic β-cells: implications for regulation of β-cell mass and biomarker development |
| Q50204465 | β Cell Aging Markers Have Heterogeneous Distribution and Are Induced by Insulin Resistance |
Search more.